Sign inGet started

LEIBOWITZ LAWRENCE E

Insider CIK 1276505 · NYX Chief Operating Officer · COWN Director · FRGE Director · CNDB Director · ENFN Director · PURR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PURR Hyperliquid Strategies Inc A Award2026-10-012026-10-151,358— —87,338SEC↗
PURR Hyperliquid Strategies Inc A Award2026-07-012026-07-062,117— $085,980SEC↗
PURR Hyperliquid Strategies Inc A Award2026-04-012026-04-023,274— $083,863SEC↗
FRGE Forge Global Holdings, Inc D To issuer deriv2026-03-022026-03-035,668— $00SEC↗
FRGE Forge Global Holdings, Inc D To issuer2026-03-022026-03-0327,588$45.00 $1.24M0SEC↗
PURR Hyperliquid Strategies Inc A Award2026-02-092026-02-1140,789— $080,589SEC↗
PURR Hyperliquid Strategies Inc J Other2025-12-042025-12-1239,800— $039,800SEC↗
FRGE Forge Global Holdings, Inc A Award2025-07-182025-07-226,073— $033,256SEC↗
FRGE Forge Global Holdings, Inc A Award2025-06-202025-06-2411,333— $027,183SEC↗
ENFN Enfusion, Inc. D To issuer2025-04-212025-04-21175,572— $00SEC↗
ENFN Enfusion, Inc. A Award2024-06-132024-06-1713,470— $0175,572SEC↗
FRGE Forge Global Holdings, Inc A Award2024-06-122024-06-13100,000— $0237,760SEC↗
FRGE Forge Global Holdings, Inc A Award2024-03-092024-03-12127,659— $0137,760SEC↗
CNDB Concord Acquisition Corp I C Conversion deriv2023-11-162023-11-1730,000— $00SEC↗
CNDB Concord Acquisition Corp I C Conversion2023-11-162023-11-1730,000— $030,000SEC↗
ENFN Enfusion, Inc. A Award2023-08-172023-08-186,335— $0162,102SEC↗
ENFN Enfusion, Inc. A Award2023-08-162023-08-1810,353— $0155,767SEC↗
ENFN Enfusion, Inc. A Award2023-08-112023-08-151,332— $0145,414SEC↗
ENFN Enfusion, Inc. A Award2023-08-102023-08-141,466— $0144,082SEC↗
ENFN Enfusion, Inc. A Award2023-08-092023-08-111,599— $0142,616SEC↗
ENFN Enfusion, Inc. A Award2023-08-082023-08-101,733— $0141,017SEC↗
ENFN Enfusion, Inc. A Award2023-06-262023-06-2815,233— $0139,284SEC↗
ENFN Enfusion, Inc. A Award2023-06-152023-06-2014,578— $0124,051SEC↗
ENFN Enfusion, Inc. A Award2023-05-242023-05-2637,396— $0109,473SEC↗
ENFN Enfusion, Inc. A Award2023-04-252023-04-277,238— $072,077SEC↗
COWN COWEN INC. D To issuer2023-03-012023-03-0142,098$39.00 $1.64M0SEC↗
COWN COWEN INC. D To issuer2023-03-012023-03-018,000$39.00 $312.0K0SEC↗
ENFN Enfusion, Inc. A Award2023-01-252023-01-277,238— $064,839SEC↗
ENFN Enfusion, Inc. A Award2022-10-252022-10-277,239— $057,601SEC↗
COWN COWEN INC. A Award2022-08-302022-09-017,672— $049,961SEC↗
ENFN Enfusion, Inc. A Award2022-06-152022-06-1712,678— $050,362SEC↗
ENFN Enfusion, Inc. A Award2021-10-312021-11-025,515— $037,684SEC↗
COWN COWEN INC. A Award2021-10-272021-10-294,720— $042,289SEC↗
COWN COWEN INC. A Award2020-07-272020-07-2810,965— $037,569SEC↗
COWN COWEN INC. P Buy2020-03-092020-03-118,000$12.13 $97.0K26,604SEC↗
COWN COWEN INC. A Award2019-07-242019-07-259,355— $018,604SEC↗
COWN COWEN INC. A Award2018-07-312018-08-029,249— $09,249SEC↗
NYX NYSE Euronext D To issuer deriv2013-11-132013-11-1337,026— $00SEC↗
NYX NYSE Euronext D To issuer deriv2013-11-132013-11-1321,295— $00SEC↗
NYX NYSE Euronext D To issuer deriv2013-11-132013-11-1327,643— $00SEC↗
NYX NYSE Euronext D To issuer deriv2013-11-132013-11-139,874— $00SEC↗
NYX NYSE Euronext D To issuer deriv2013-11-132013-11-1331,232— $00SEC↗
NYX NYSE Euronext D To issuer deriv2013-11-132013-11-1343,193— $00SEC↗
NYX NYSE Euronext D To issuer2013-11-132013-11-13109,358— $00SEC↗
NYX NYSE Euronext C Conversion deriv2013-02-112013-02-1213,822— $027,643SEC↗
NYX NYSE Euronext C Conversion2013-02-112013-02-1213,822— $0117,074SEC↗
NYX NYSE Euronext F Tax w/h2013-02-112013-02-127,716$36.24 $279.6K109,358SEC↗
NYX NYSE Euronext C Conversion deriv2013-02-102013-02-1213,037— $00SEC↗
NYX NYSE Euronext C Conversion deriv2013-02-102013-02-1252,854— $00SEC↗
NYX NYSE Euronext F Tax w/h2013-02-102013-02-1234,192$36.24 $1.24M103,252SEC↗
NYX NYSE Euronext C Conversion2013-02-102013-02-1252,854— $0137,444SEC↗
NYX NYSE Euronext C Conversion2013-02-102013-02-1213,037— $084,590SEC↗
NYX NYSE Euronext C Conversion deriv2013-02-082013-02-129,873— $09,874SEC↗
NYX NYSE Euronext F Tax w/h2013-02-082013-02-124,089$36.14 $147.8K71,553SEC↗
NYX NYSE Euronext C Conversion2013-02-082013-02-129,873— $075,642SEC↗
NYX NYSE Euronext A Award deriv2013-02-062013-02-0831,232— $031,232SEC↗
NYX NYSE Euronext A Award deriv2013-02-062013-02-0821,295— $021,295SEC↗
NYX NYSE Euronext J Other2012-02-132012-02-1421,809— $065,769SEC↗
NYX NYSE Euronext A Award deriv2012-02-112012-02-1043,193— $043,193SEC↗
NYX NYSE Euronext A Award deriv2012-02-112012-02-1041,465— $041,465SEC↗
NYX NYSE Euronext C Conversion deriv2012-02-102012-02-1469,093— $00SEC↗
NYX NYSE Euronext C Conversion deriv2012-02-102012-02-1413,435— $00SEC↗
NYX NYSE Euronext C Conversion deriv2012-02-102012-02-1413,037— $013,037SEC↗
NYX NYSE Euronext F Tax w/h2012-02-102012-02-1445,471$27.69 $1.26M87,578SEC↗
NYX NYSE Euronext C Conversion2012-02-102012-02-1413,037— $0133,049SEC↗
NYX NYSE Euronext C Conversion2012-02-102012-02-1469,093— $0106,577SEC↗
NYX NYSE Euronext C Conversion2012-02-102012-02-1413,435— $0120,012SEC↗
NYX NYSE Euronext C Conversion deriv2012-02-082012-02-099,874— $019,747SEC↗
NYX NYSE Euronext F Tax w/h2012-02-082012-02-094,017$27.82 $111.8K37,484SEC↗
NYX NYSE Euronext C Conversion2012-02-082012-02-099,874— $041,501SEC↗